Comparing isotretinoin to standard care for moderate acne in darker skin
Treatments studied
Part of Skin clinical trials.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 30 years old
- You have a darker skin type (Fitzpatrick IV, V, or VI)
- Your acne is moderate (not mild, not severe)
- You have a cell phone that can take clear selfies (at least 5 megapixels)
- You have French health insurance (social coverage)
- You have not taken isotretinoin before, or oral antibiotics for acne in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This study compares two doses of an acne pill called isotretinoin to see if a lower dose works as well as the standard dose with fewer side effects. If you have moderate to severe acne, this trial might help you find an effective treatment with less risk of side effects.
This study looks at how the bacteria on your face change when you take a medicine called isotretinoin for acne. It might help doctors understand why the medicine works and how to improve acne treatment.
This study looks at how a woman's natural hormone levels affect how well she responds to isotretinoin (a strong acne pill). It aims to help doctors predict which patients will benefit most from this treatment.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests a cream called KR230109 for mild to moderate facial acne. The goal is to see if the cream is safe and helps reduce pimples and blackheads/whiteheads. You will be asked to use the cream as directed and attend study visits.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.